Fundraising FoxKIKK Capital — 2022 Investments
1 investments dated 2022 · listed companies and verified rows first · show all
River BioMedicsriverbiomedics.cominJan 2022
River Biomedics develops human cardiac in vitro models used for drug target and compound validation, building a pipeline of cardiac therapies.
BiotechHealthtechMedical Devices
Robert Passier(Founder)in
Co-investorsBioGeneration VenturesBGVOost NL
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.